No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract ENESTnd: Frontline nilotinib therapy shows improvement in long-term efficacy outcomes for patients in the chronic phase of newly diagnosed chronic myeloid leukemia

byKathleen Lau

February 4, 2021

in StudyGraphics

#VisualAbstract ENESTnd: Frontline nilotinib therapy shows improvement in long-term efficacy outcomes for patients in the chronic phase of newly diagnosed chronic myeloid leukemia

Hypertension and obesity associated with changes in retinal microvasculature for children

RelatedReports

A stylized illustration featuring the pancreas and kidney, with visual elements suggesting pain and chemotherapy effects, related to pancreatic cancer treatment.

Artificial Intelligence

Routine CT scans show steeper fat loss years before pancreatic cancer diagnosis

October 30, 2026

An illustration depicting the colon with IV bags on either side, symbolizing sequential therapy paths in colorectal cancer treatment.

Gastroenterology

FDA approves dostarlimab (Jemperli) for certain patients with locally advanced rectal cancer

October 29, 2026

A calendar, a specimen jar, and a brush are depicted alongside a microscopic view of cervical cells, indicating cervical cancer screening.

All Specialties

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

October 23, 2026

A liver illustration with spilled sugar cubes and two drink cups, highlighting the link between sugary drinks and liver health.

Chronic Disease

Male sex is associated with higher mortality among patients with hepatocellular carcinoma

October 7, 2026

#VisualAbstract: Fixed-dose, subcutaneous injection of pertuzumab and trastuzumab is noninferior to intravenous administration in HER2⁺ breast cancer

#VisualAbstract: Incidence and prevalence of melanomas and keratinocyte carcinomas have increased from 1990 to 2017

Tocilizumab is superior to rituximab for treatment of rheumatoid arthritis in patients with low or absent B-cell lineage expression

$Phase II O-12-M1: Melflufen plus dexamethasone showed benefits in long-term survival outcomes in relapsed/refractory multiple myeloma$

Phase II O-12-M1: Melflufen plus dexamethasone showed benefits in long-term survival outcomes in relapsed/refractory multiple myeloma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract ENESTnd: Frontline nilotinib therapy shows improvement in long-term efficacy outcomes for patients in the chronic phase of newly diagnosed chronic myeloid leukemia

Routine CT scans show steeper fat loss years before pancreatic cancer diagnosis

FDA approves dostarlimab (Jemperli) for certain patients with locally advanced rectal cancer

Hypertension and obesity associated with changes in retinal microvasculature for children

#VisualAbstract: Incidence and prevalence of melanomas and keratinocyte carcinomas have increased from 1990 to 2017

RelatedReports

Routine CT scans show steeper fat loss years before pancreatic cancer diagnosis

FDA approves dostarlimab (Jemperli) for certain patients with locally advanced rectal cancer

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

Male sex is associated with higher mortality among patients with hepatocellular carcinoma

#VisualAbstract: Incidence and prevalence of melanomas and keratinocyte carcinomas have increased from 1990 to 2017

Tocilizumab is superior to rituximab for treatment of rheumatoid arthritis in patients with low or absent B-cell lineage expression

Phase II O-12-M1: Melflufen plus dexamethasone showed benefits in long-term survival outcomes in relapsed/refractory multiple myeloma

2MM+ All Access

Look up any US clinician

Recent Reports

Get the app

Keep reading with 2 Minute Medicine+

Keep reading with 2 Minute Medicine+

The medical literature, distilled daily.

Membership benefits

#VisualAbstract ENESTnd: Frontline nilotinib therapy shows improvement in long-term efficacy outcomes for patients in the chronic phase of newly diagnosed chronic myeloid leukemia

RELATED REPORTS

Hypertension and obesity associated with changes in retinal microvasculature for children

#VisualAbstract: Incidence and prevalence of melanomas and keratinocyte carcinomas have increased from 1990 to 2017

RelatedReports

2MM+ All Access

Look up any US clinician

Recent Reports

Get the app

Keep reading with 2 Minute Medicine+

Keep reading with 2 Minute Medicine+

The medical literature, distilled daily.

Membership benefits